
Baxter BioPharma Solutions
Advertisement
Articles by Baxter BioPharma Solutions


Your oncology product can make a difference in patients’ lives, and our oncology manufacturing expertise can help you make that difference.


- Advantages of manufacturing immuno-oncology therapies in multiproduct facilities - Preventing cross-contamination and proper cleaning validation

This case study looks at considerations for formulations of Mannitol, a versatile excipient used in freeze-dried injectables in the pharmaceutical industry.
Advertisement
Latest Updated Articles
 Complex Sterile Manufacturing of Oncology Products Complex Sterile Manufacturing of Oncology Products- Published: October 20th 2020 | Updated: 
 Hemihydrate Formation: Considerations for Mannitol Formulations Hemihydrate Formation: Considerations for Mannitol Formulations- Published: February 24th 2020 | Updated: 
 Oncology Product Manufacturing in a Non-Dedicated Facility Oncology Product Manufacturing in a Non-Dedicated Facility- Published: March 19th 2020 | Updated: 
 Oncology Product Manufacturing in a Nondedicated Facility Oncology Product Manufacturing in a Nondedicated Facility- Published: March 19th 2020 | Updated: 
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
4
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
5
